5 Feb 2016 10:16
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
 |  | |||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | BTG plc | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | ü | |||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | Â | |||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | Â | |||
An event changing the breakdown of voting rights | Â | |||
Other (please specify): | Â | Â | ||
3. Full name of person(s) subject to thenotification obligation: | Novo Nordisk Foundation | |||
4. Full name of shareholder(s)Â (if different from 3.): | Novo A/S | |||
5. Date of the transaction and date onwhich the threshold is crossed orreached: | 3 February 2016 | |||
6. Date on which issuer notified: | 5 February 2016 | |||
7. Threshold(s) that is/are crossed orreached: | 8% | |||
 |  |  |  |  |
Â
8. Notified details: | |||||||||||||||||
A: Voting rights attached to shares | |||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights | |||||||||||||
Direct | Direct | Indirect | Direct | Indirect | |||||||||||||
Ordinary 10 pence shares ISIN: GB0001001592 | 30,164,466 | 7.88% | 31,080,068 | 31,080,068 | - | 8.12% | - | ||||||||||
 | |||||||||||||||||
 | |||||||||||||||||
B: Qualifying Financial Instruments | |||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||
Type of financialinstrument | Expirationdate | Exercise/Conversion Period | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | |||||||||||||
N/A | - | - | - | - | |||||||||||||
 | |||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | |||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date | Exercise/Conversion period | Number of voting rights instrument refers to  | % of voting rights  | ||||||||||||
N/A | - | - | - | - Â | Nominal | Delta | |||||||||||
- | - | ||||||||||||||||
 | |||||||||||||||||
Total (A+B+C) | |||||||||||||||||
Number of voting rights | Percentage of voting rights | ||||||||||||||||
31,080,068 | 8.12% | ||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Â
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | ||
 The qualifying instruments are held by Novo A/S, the holding company in the Novo Group. Novo A/S is wholly owned by the Novo Nordisk Foundation. | ||
 | ||
Proxy Voting: | ||
10. Name of the proxy holder: | - | |
11. Number of voting rights proxy holder will ceaseto hold: | - | |
12. Date on which proxy holder will cease to holdvoting rights: | - | |
 | ||
13. Additional information: | Â - | |
14. Contact name: |  Andy Burrows, Vice President, Corporate and Investor Relations, BTG plc  | |
15. Contact telephone number: | 020 7575 1741 | |
 |  |  |
Â
Â